The UK pharmaceutical giant has announced a landmark $15bn China investment during the UK prime minister’s visit, marking its largest expansion yet to boost manufacturing, R&D and biotech collaboration.

Hong Kong's finance chief discussed opportunities in the Northern Metropolis, developing AI, foreign tech firms entering the SAR, green finance, and China's evolving role in supply chains.

Every year, FinanceAsia publishes a highly recognised benchmark of Asia's best companies, made by asking influential investors and analysts to nominate Asian companies that are leading in their sector.

The digital bank, which has operations in China, Hong Kong and Indonesia, is looking at M&A opportunities and developing artificial intelligence agents, with the debt and equity fundraise.

Every year, FinanceAsia publishes a highly recognised benchmark of Asia's best companies, made by asking influential investors and analysts to nominate Asian companies that are leading in their sector. We invite our readers to participate by nominating any Asia-based publicly-listed company that is leading in its sector.

Samantha Horton, group chief operating officer and head of international at Syfe, explained to FA some of the mechanics, challenges and attractions of the 2025 deal for the listed firm, and also future regional expansion plans.

YP05002, developed by Yao Pharma, is in Phase 1 clinical development in Australia and can potentially help with metabolic diseases; Yao Pharma will receive an upfront payment of $150m for a worldwide licence.

It is the group's largest public IABS issuance to date and its first in the Rule 144A/Reg S format with US onshore investors involved. Clifford Capital's group CEO told FA the deal "reflects the growing interest and appetite in infrastructure returns from institutional investors".

HKEX to welcome Middle Eastern issuer soon, while Xiaomi hopes to bring its EV products to Europe.

Beijing is encouraging A-share listed firms to list in Hong Kong, while Trump’s policies are turning some US-listed Chinese companies to also go public on HKEX. The IPO momentum is continuing with four firms listing on October 28 in the SAR.